Phenoxymethylpenicillin Crescent 250mg Tablets

Ülke: Malta

Dil: İngilizce

Kaynak: Medicines Authority

Aktif bileşen:

PHENOXYMETHYLPENICILLIN

Mevcut itibaren:

Crescent Pharma International Limited 260, Triq San Albert, Gzira GZR 1150, Malta

ATC kodu:

J01CE02

INN (International Adı):

PHENOXYMETHYLPENICILLIN 250 mg

Farmasötik formu:

TABLET

Kompozisyon:

PHENOXYMETHYLPENICILLIN 250 mg

Reçete türü:

POM

Terapötik alanı:

ANTIBACTERIALS FOR SYSTEMIC USE

Yetkilendirme durumu:

Authorised

Yetkilendirme tarihi:

2019-05-20

Bilgilendirme broşürü

PATIENT INFORMATION LEAFLET
PHENOXYMETHYLPENICILLIN CRESCENT 250MG TABLETS
Phenoxymethylpenicillin
KEEP THE LEAFLET; YOU MAY NEED TO READ IT AGAIN. IF YOU HAVE ANY
QUESTIONS OR
ARE NOT
SURE ABOUT
ANYTHING, ASK
YOUR DOCTOR OR
PHARMACIST.
THIS
MEDICINE HAS BEEN
PRESCRIBED FOR
YOU. DO NOT PASS IT ON TO
OTHERS. IT MAY HARM
THEM, EVEN IF THEIR
SYMPTOMS ARE
THE SAME AS
YOURS.
IF YOU GET ANY SIDE EFFECTS, TALK TO YOUR DOCTOR, PHARMACIST OR NURSE.
THIS INCLUDES ANY
SIDE EFFECTS NOT LISTED IN THIS LEAFLET. SEE SECTION 4.
IN THIS
LEAFLET:
1.
What Phenoxymethylpenicillin Tablets are and what they are used for
2. Before you take Phenoxymethylpenicillin Tablets
3
.
How to take Phenoxymethylpenicillin Tablets
4. Possible side effects
5. How to store Phenoxymethylpenicillin Tablets
6. Further information
1. WHAT
PHENOXYMETHYLPENICILLIN TABLETS
ARE AND WHAT THEY ARE USED
FOR
This medicine belongs to the penicillin group of antibiotics.
It
is an antibacterial drug used
in the treatment of mild to moderately severe infections such as chest
and throat
infections
,
skin and soft
t
i
ssue
infections
,
infections of the mouth
,
gums and teeth
,
scarlet fever
(characterised by high fever, sore throat and skin rashes) and mild
erysipelas (a disease
marked by red skin
eruptions
,
chills and fever).
It
is also used in the prevention of
rheumatic fever and chorea (a group of disorders characterised by
brief rapid involuntary
movements of limbs, face, trunk and head).
2. BEFORE YOU TAKE
PHENOXYMETHYLPENICILLIN TABLETS
DO NOT TAKE THESE TABLETS
IF:
•
you are allergic to Phenoxymethylpenicillin or to any of the other
ingredients (see
section 6).
CHECK WITH YOUR DOCTOR BEFORE TAKING THESE TABLETS
IF:
•
you have a history of allergic reaction to penicillins, cephalosporins
or other allergy
causing agents
•
you are suffering from severe illness, nausea, vomiting, stomach
bloating/cramping,
difficulty swallowing or chest pain you have kidney problems
•
you are pregnant, think you may be pregnant or you are breast feeding.
(This
medicine i

Ürün özellikleri

SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE MEDICINAL PRODUCT
Phenoxymethylpenicillin Crescent 250 mg Tablets
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
_ _
Each tablet contains Phenoxymethylpenicillin Potassium (1515 I-U/mg)
BP 280.00 mg
3.
PHARMACEUTICAL FORM
White, flat bevelled edged tablets, engraved on one side with company
logo and with breakline and
A057 on the other side.
4.
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
Phenoxymethylpenicillin and potassium phenoxymethylpenicillin are
indicated in the treatment of
mild to moderately severe infections associated with micro-organisms
whose susceptibility to
penicillin is within the range of serum levels attained with these
dosage forms. The following
infections will usually respond to adequate doses:
Streptococcal infections (without bacteraemia): Mild to moderate
infections of the upper respiratory
tract, scarlet fever and mild erysipelas.
Pneumococcal infections: Mild to moderately severe infections of the
respiratory tract.
Staphylococcal infections sensitive to penicillin: Mild infections of
the skin and soft tissues.
Fusospirochaetosis (vincent’s gingivitis and pharyngitis): Mild to
moderately severe infections of the
oropharynx usually respond to therapy with oral penicillin.
Prophylactic use: Prophylaxis with oral penicillin has proved
effective in preventing recurrence of
rheumatic fever and chorea.
Patients with a past history of rheumatic fever receiving continuous
prophylaxis may harbour
penicillin-resistant organisms. In these patients, the use of another
prophylactic agent should be
considered.
Note: Severe empyema, bacteraemia, pericarditis, meningitis and
arthritis should not be treated with
Phenoxymethylpenicillin during the acute phase.
Consideration should be given to official guidance on the appropriate
use antibacterial agent.
Posology and method of administration
Adults:
125 – 500 mg every 4 – 6 hours depending on the severity of the
condition.
Prophylactic use:
125 mg twice daily is recommended for long term prophylaxi